Patent applications published 10 November 2010
Selected patent applications from the weekly European Patents Bulletin
- Methods and compsns for inhibiting progression to chronic heart failure
Foker, John 2247183*
- Dual pharmacophores-PDE4-muscarinic antagonists
Glaxo Group 2247184*
- Tyrosine kinase inhibitors
Tiger Pharmatech 2247185*
- Protein-based sheet material for in vitro testing
Fujifilm Manufacturing Europe 2247281*
- Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
Novartis 2247282*
- Micronised opioid compsns, formulations and dosage forms and methods of making same
Pain Therapeutics 2247283*
- Process to minimise polymorphism
RP Scherer Technologies 2247284*
- Cellular therapeutic agent for incontinence of urine comprising stem cells originated from decidua or adipose
RNL Bio 2247285*
- Alcohol antimicrobial skin sanitising compsns including cationic compatible thickeners
Kimberley-Clark Worldwide 2247286*
- Use of hedgehog agonists in the treatment of musculoskeletal-related disorders
Novartis 2247288*
- Ophthalmic NSAIDS as adjuvants
Isa Pharmaceuticals; Senju Pharmaceutical 2247289*
- Polyphenols for the treatment of cartilage disorders
Nestec 2247290*
- Methods and compsns for treating inflammatory bowel disorder
Giaconda 2247291*
- Pyridopyrazinones derivatives, insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
Merck Patent 2247292*
- Novel compsns and methods for treatment of diseases related to activated lymphocytes
Immune Control 2247293*
- Macrolides for treating diseases mediated through PDE inhibition
Basilea Pharmaceutica 2247294*
- Compsn for improving liver metabolism and diagnostic method
Valio 2247295*
- Use of Hypericum perforatum extracts in the treatment of neuropathic pain
Aboca 2247296*
- Therapeutic treatment for lung conditions
Vanderbilt University 2247297*
- Control of viral-host membrane fusion with hydrogen bond surrogate-based artificial helices
New York University 2247298*
- Molecular targets for treatment of inflammation
University of Rochester 2247299*
- MNTF peptides compsns and methods of use
Genervon Biopharmaceuticals 2247300*
- Use of therapeutic peptides for the treatment and prevention of cancer
Arizona Biomedical Research Commission 2247301*
- An engineered CXCL12 alpha locked dimer polypeptide
MCW Research Foundation; The Rockefeller University 2247302*
- Haemostasis-modulating compsns and uses therefor
The University of Queensland; Venomics 2247303*
- HER2/NEU-specific antibodies and methods of using same
MacroGenics 2247304*
- Stabilised angiopoietin-2 antibodies and uses thereof
MedImmune 2247305*
- Immunogenic control of tumours and tumour cells
Life Sciences Research Partners 2247306*
- Vaccine
GlaxoSmithKline Biologicals 2247307*
- Adjuvant compsns comprising poly-IC and a cationic polymer
Nventa Biopharmaceuticals 2247308*
- Tapasin augmentation for enhanced immune response
Tapimmune 2247309*
- Compsns and methods for crystallising antibody fragments
Abbott Laboratories 2247310*
- Compsns for delivery of cargo such as drug, proteins and/or genetic materials
Terapio 2247311*
- Compsn and methods for the treatment of tumours of haematopoietic origin
Genentech 2247312*
- Acid salt of tolterodine having effective stability for transdermal drug delivery system
SK Chemicals 2247569*
- Novel salts of O-desmethyl-venlafaxine
LEK Pharmaceuticals 2247570*
- Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
Uniwesytet Jagiellonski 2247571*
- A one-pot process for preparing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate
Grindeks 2247572*
- Carbionic and sulphuric acid salts of 3-(2,2,2-trimethylhydrazinium)propionate esters and their use for 3-(2,2,2-trimethyl-hydrazinium)propionate dihydrate preparation
Grindeks 2247573*
- Sulphonated estolides and other derivatives of fatty acids, methods of making them, and compsns and processes employing them
Stepan 2247574*
- Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
Sanofi-Aventis 2246575*
- Inhibitors for brassinosteroid signalling
GMI-Gregor-Mendel-Institut für Molekulare Pflanzenbiologie 2247576*
- Method for the regioselective synthesis of 1-alkyl-3-haloalkyl pyrazole-4-carboxylic acid derivatives
Bayer Cropscience 2247577*
- Hydroxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
Array Biopharma; Genentech 2247578*